Journal of Diabetes and Its Complications
Volume 21, Issue 3 , Pages 196-204 , May 2007

Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies

  • William Duckworth

      Affiliations

    • Carl T. Hayden VA Medical Center, Arizona State University, Phoenix, AZ, USA
    • Corresponding Author InformationCorresponding author. Carl T. Hayden VA Medical Center, Mailcode Cs-111e, 650 E. Indian School Road, Phoenix, AZ 85012, USA. Tel.: +1 602 277 5551x6802.
    • ,
  • Stephen N. Davis

      Affiliations

    • Vanderbilt University Nashville, Nashville, TN, USA

Received 7 July 2006 ,Accepted 13 December 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Support: This manuscript was supported by sanofi-aventis U.S. Many of the studies reported within this manuscript have also been supported by sanofi-aventis US.

☆☆ Conflict of interest statement: Dr. William Duckworth has received research grant support from Novo Nordisk Pharmaceuticals, Inc., sanofi-aventis U.S., Roche Diagnostics, and Kos Pharmaceuticals, Inc.; has been a consultant for Novo Nordisk Pharmaceuticals, Inc., and sanofi-aventis U.S.; and has been involved with the Bristol-Myers Squibb speakers bureau. Dr. Stephen Davis has received grant support from sanofi-aventis U.S. and Eli Lilly and Company.

★ Disclaimer: Reference herein to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government, and shall not be used for advertising or product endorsement purposes.

PII: S1056-8727(07)00007-4

doi: 10.1016/j.jdiacomp.2007.01.001

Journal of Diabetes and Its Complications
Volume 21, Issue 3 , Pages 196-204 , May 2007

Article Tools

* Image Usage & Resolution